相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect on anterior chamber bevacizumab injection combined with seton implantation in treatment of rubeosis iridis in Neovascular Glaucoma
Ayse Gul Kocak Altintas et al.
CUTANEOUS AND OCULAR TOXICOLOGY (2012)
Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration
Matthew Ohr et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma
Tomomi Higashide et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration
Nurit Mathalone et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2012)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Short-term effects of intravitreal bevacizumab (Avastin®) on retrobulbar hemodynamics in patients with neovascular age-related macular degeneration
Yasin Toklu et al.
ACTA OPHTHALMOLOGICA (2011)
Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
Travis J. Good et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens
Noriko Yoshida et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Combined Intravitreal Bevacizumab and Trabeculectomy With Mitomycin C Versus Trabeculectomy With Mitomycin C Alone for Neovascular Glaucoma
Yuji Takihara et al.
JOURNAL OF GLAUCOMA (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
SUSTAINED ELEVATED INTRAOCULAR PRESSURES AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, RANIBIZUMAB, AND PEGAPTANIB
Daniel Y. Choi et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
Michael Tolentino
SURVEY OF OPHTHALMOLOGY (2011)
ISRCTN12125882-Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol
Frank Bochmann et al.
BMC OPHTHALMOLOGY (2011)
Response of Retinal Vessels and Retrobulbar Hemodynamics to Intravitreal Anti-VEGF Treatment in Eyes with Branch Retinal Vein Occlusion
Stefan Sacu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Retinal artery occlusion following intravitreal anti-VEGF therapy
Therese von Hanno et al.
ACTA OPHTHALMOLOGICA (2010)
Clinical Factors Related to Recurrence of Anterior Segment Neovascularization After Treatment Including Intravitreal Bevacizumab
Yoshiaki Saito et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Bleb Morphology and Vascularity After Trabeculectomy With Intravitreal Ranibizumab: A Pilot Study
Malik Y. Kahook
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2
Prema Abraham et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Pegaptanib sodium as maintenance therapy in neovascular age-related macular degeneration: the LEVEL study
Thomas R. Friberg et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2010)
Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients
Yosuke Sugimoto et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Surgical Outcomes of Intravitreal Bevacizumab and Guarded Filtration Surgery in Neovascular Glaucoma
Ghasem Fakhraie et al.
JOURNAL OF GLAUCOMA (2010)
In Vitro Effects of Antivascular Endothelial Growth Factors on Cultured Human Trabecular Meshwork Cells
Malik Y. Kahook et al.
JOURNAL OF GLAUCOMA (2010)
Antifibrotic Activity of Bevacizumab on Human Tenon's Fibroblasts In Vitro
Evelyn C. O'Neill et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Combined Treatment with Bevacizumab and 5-Fluorouracil Attenuates the Postoperative Scarring Response after Experimental Glaucoma Filtration Surgery
Alicia How et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor concentrations in neovascular glaucoma
S. Grover et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2009)
Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients
K. Spiteri Cornish et al.
EYE (2009)
Level of Vascular Endothelial Growth Factor in Aqueous Humor and Surgical Results of Ahmed Glaucoma Valve Implantation in Patients With Neovascular Glaucoma
Yong Guk Kim et al.
JOURNAL OF GLAUCOMA (2009)
Intravitreal Bevacizumab for Neovascular Glaucoma A Randomized Controlled Trial
Shahin Yazdani et al.
JOURNAL OF GLAUCOMA (2009)
Sustained Elevation in Intraocular Pressure Associated With Intravitreal Bevacizumab Injections
Malik Y. Kahook et al.
OPHTHALMIC SURGERY LASERS & IMAGING (2009)
Long-term Outcomes of Intraoperative 5-Fluorouracil versus Intraoperative Mitomycin C in Primary Trabeculectomy Surgery
Angelita M. Palanca-Capistrano et al.
OPHTHALMOLOGY (2009)
Angiogenesis: Trabeculectomy and Bevacizumab
Andrea Jue
SEMINARS IN OPHTHALMOLOGY (2009)
Neovascular Glaucoma: Etiology, Diagnosis and Prognosis
Tarek A. Shazly et al.
SEMINARS IN OPHTHALMOLOGY (2009)
Postoperative Use of Bevacizumab as an Antifibrotic Agent in Glaucoma Filtration Surgery in the Rabbit
Farnaz Memarzadeh et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma
Naris Kitnarong et al.
ADVANCES IN THERAPY (2008)
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1
Carl D. Regillo et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy
Siamak Moradian et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
Evaluation of Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy: A Pilot Study
Ditraj S. Grewal et al.
OPHTHALMOLOGY (2008)
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases
Taku Wakabayashi et al.
OPHTHALMOLOGY (2008)
Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma
Justis P. Ehlers et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy
J. F. Arevalo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Intravitreal bevacizumab (Avastin) causing acute glaucoma: an unreported complication
A. Jalil et al.
EYE (2007)
Role of intravitreal bevacizumab in neovascular glaucoma
Moataz E. Gheith et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Safety profile of bevacizumab on cultured human corneal cells
Efdal Yoeruek et al.
CORNEA (2007)
Visual side effects of successful scatter laser photocoagulation surgery for proliferative diabetic retinopathy
Donald S. Fong et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
Intravitreal bevacizumab (Avastin®) in the treatment of neovascular glaucoma
Milko E. Iliev et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
Christos Haritoglou et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells
M. S. Spitzer et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy
Robert L. Avery et al.
OPHTHALMOLOGY (2006)
Regression of neovascular iris vessels by intravitreal injection of bevacizumab
John O. Mason et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy
Yusuke Oshima et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Intracameral bevacizumab for iris rubeosis
Salvatore Grisanti et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Evaluation of in vitro effects of bevacizumab (avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells
Saurabh Luthra et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion - A short-term study
Diana Iturralde et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Antifibrotics and wound healing in glaucoma surgery
PJ Lama et al.
SURVEY OF OPHTHALMOLOGY (2003)
Vascular-specific growth factors and blood vessel formation
GD Yancopoulos et al.
NATURE (2000)
分享论文
